BE Therapeutics
PrivateLast Round
Seed
Nov 16, 2023
Total Funding Raised
$3.6M
Company Overview
BE Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in November 2023.
BE Therapeutics is a biotechnology company that develops regenerative medicine therapies designed to repair and restore damaged brain and spinal cord tissue.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BE Therapeutics Comparables
Compare BE Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innervace | 81% | |
| Spiderwort | 78% | |
| UCB | 77% |
For institutional investors. Book with your work email.
BE Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
BE Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Empire State Development | Seed |
| Longevitytech.fund | Seed |
| Healthspan Capital | Seed |
| Alumni Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 24, 2024
Grew 133% QoQ, from 3 to 7 employees.
- Apr 27, 2024
Grew 250% QoQ, from 2 to 7 employees.
For institutional investors. Book with your work email.
BE Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BE Therapeutics's valuation, stock price, and market status.
Is BE Therapeutics a public or private company?
BE Therapeutics is a private company.
What is the current stock price of BE Therapeutics?
BE Therapeutics is a private company, so its shares have no public market price. Caplight tracks BE Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BE Therapeutics worth (valuation)?
Valuation information for BE Therapeutics is not publicly available.
Can I buy BE Therapeutics stock?
BE Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BE Therapeutics's last funding round?
BE Therapeutics's most recent funding round was Seed on November 16, 2023.
Who are the main investors in BE Therapeutics?
Key investors in BE Therapeutics include Empire State Development, Longevitytech.fund, Healthspan Capital, Alumni Ventures.
Will BE Therapeutics IPO soon?
No public IPO plans have been announced for BE Therapeutics.
How can I track BE Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in BE Therapeutics's shares on secondary markets.